Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 353

    1.

    The risk of stroke in postmenopausal women receiving hormonal therapy.

    Lobo RA.

    Climacteric. 2009;12 Suppl 1:81-5.PMID: 19811248 [PubMed - in process]Related articles

    2.

    Using Basic Science to Design a Clinical Trial: Baseline Characteristics of Women Enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).

    Miller VM, Black DM, Brinton EA, Budoff MJ, Cedars MI, Hodis HN, Lobo RA, Manson JE, Merriam GR, Naftolin F, Santoro N, Taylor HS, Harman SM.

    J Cardiovasc Transl Res. 2009 Sep;2(3):228-239. Epub 2009 May 22.PMID: 19668346 [PubMed]Related articlesFree article

    3.

    Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.

    Lobo RA, Pinkerton JV, Gass ML, Dorin MH, Ronkin S, Pickar JH, Constantine G.

    Fertil Steril. 2009 Sep;92(3):1025-38. Epub 2009 Jul 26.PMID: 19635615 [PubMed - indexed for MEDLINE]Related articles

    4.

    Paraneoplastic anti-N-methyl-d-aspartate-receptor encephalitis from mature cystic teratoma.

    Kort DH, Vallerie AM, DeMarco EF, Lobo RA.

    Obstet Gynecol. 2009 Aug;114(2 Pt 1):373-6. No abstract available. PMID: 19623000 [PubMed - indexed for MEDLINE]Related articles

    5.

    Correlates of increased lean muscle mass in women with polycystic ovary syndrome.

    Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA.

    Eur J Endocrinol. 2009 Oct;161(4):583-9. Epub 2009 Jul 15.PMID: 19605540 [PubMed - indexed for MEDLINE]Related articles

    6.

    Inter- and intra-tester reliability of clinical measurement to determine medio-lateral patellar position using a pachymeter or visual assessment.

    Sacco IC, Onodera AN, Butugan MK, Taddei UT, Mendes YC, Galhardo B, Padua M, Dreyer SH, Lobo RA, Aliberti S.

    Knee. 2010 Jan;17(1):92-5. Epub 2009 Jul 1.PMID: 19574052 [PubMed - in process]Related articles

    7.

    Coronary heart disease and menopause management: The swinging pendulum of HRT.

    Stevenson JC, Hodis HN, Pickar JH, Lobo RA.

    Atherosclerosis. 2009 Jun 6. [Epub ahead of print]PMID: 19560146 [PubMed - as supplied by publisher]Related articles

    8.

    Not all women diagnosed with PCOS share the same cardiovascular risk profiles.

    Jovanovic VP, Carmina E, Lobo RA.

    Fertil Steril. 2009 Jun 4. [Epub ahead of print]PMID: 19501355 [PubMed - as supplied by publisher]Related articles

    9.

    Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and visceral abdominal fat.

    Vardhana PA, Dicken C, Tortoriello DV, Chu M, Carmina E, Lobo RA.

    Int J Gynaecol Obstet. 2009 Feb;104(2):121-4. Epub 2008 Nov 22.PMID: 19027899 [PubMed - indexed for MEDLINE]Related articles

    10.

    Correlation between water-drinking test outcomes and body mass index in primary open-angle glaucoma patients under clinical treatment.

    Lima VC, Prata TS, Lobo RA, Paranhos A Jr.

    J Ocul Pharmacol Ther. 2008 Oct;24(5):513-6.PMID: 18800868 [PubMed - indexed for MEDLINE]Related articles

    11.

    Inflammation, coronary artery disease, and hormones.

    Lobo RA.

    Menopause. 2008 Nov-Dec;15(6):1036-8. No abstract available. PMID: 18779754 [PubMed - indexed for MEDLINE]Related articles

    12.

    Evidence-based approach to menopause. Foreword.

    Lobo RA.

    Clin Obstet Gynecol. 2008 Sep;51(3):533. No abstract available. PMID: 18677146 [PubMed - indexed for MEDLINE]Related articles

    13.

    Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.

    Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein F, Heiman JR, Henderson VW, Hodis HN, Karas RH, Lobo RA, Manson JE, Reid RL, Schmidt PJ, Stuenkel CA; North American Menopause Society.

    Menopause. 2008 Jul-Aug;15(4 Pt 1):584-602.PMID: 18580541 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers.

    Chu MC, Cushman M, Solomon R, Lobo RA.

    Am J Obstet Gynecol. 2008 Nov;199(5):526.e1-7. Epub 2008 Jun 3.PMID: 18511016 [PubMed - indexed for MEDLINE]Related articles

    15.

    Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome.

    Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo RA.

    Fertil Steril. 2009 Apr;91(4 Suppl):1332-5. Epub 2008 May 2.PMID: 18455165 [PubMed - indexed for MEDLINE]Related articles

    16.

    Metabolic syndrome after menopause and the role of hormones.

    Lobo RA.

    Maturitas. 2008 May 20;60(1):10-8. Epub 2008 Apr 14. Review.PMID: 18407440 [PubMed - indexed for MEDLINE]Related articles

    17.

    Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial).

    Hodis HN, St John JA, Xiang M, Cushman M, Lobo RA, Mack WJ.

    Am J Cardiol. 2008 Apr 15;101(8):1131-3. Epub 2008 Feb 14.PMID: 18394446 [PubMed - indexed for MEDLINE]Related articles

    18.

    Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

    Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, Shapiro J, Montori VM, Swiglo BA.

    J Clin Endocrinol Metab. 2008 Apr;93(4):1105-20. Epub 2008 Feb 5. Review.PMID: 18252793 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome.

    Wang JG, Lobo RA.

    J Clin Endocrinol Metab. 2008 Apr;93(4):1394-7. Epub 2008 Jan 29.PMID: 18230664 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.

    Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M.

    Obstet Gynecol. 2008 Jan;111(1):67-76.PMID: 18165394 [PubMed - indexed for MEDLINE]Related articles

    21.

    Menopause and stroke and the effects of hormonal therapy.

    Lobo RA.

    Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.PMID: 17882669 [PubMed - indexed for MEDLINE]Related articles

    22.

    Postmenopausal hormones and coronary artery disease: potential benefits and risks.

    Lobo RA.

    Climacteric. 2007 Oct;10 Suppl 2:21-6. Review.PMID: 17882668 [PubMed - indexed for MEDLINE]Related articles

    23.

    Triplet pregnancy after ovulation induction with an aromatase inhibitor.

    Dicken CL, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA.

    Fertil Steril. 2008 Oct;90(4):1199.e9-11. Epub 2007 Oct 22.PMID: 17953943 [PubMed - indexed for MEDLINE]Related articles

    24.

    Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.

    Karim R, Hodis HN, Stanczyk FZ, Lobo RA, Mack WJ.

    J Clin Endocrinol Metab. 2008 Jan;93(1):131-8. Epub 2007 Oct 9.PMID: 17925335 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Surgical menopause and cardiovascular risks.

    Lobo RA.

    Menopause. 2007 May-Jun;14(3 Pt 2):562-6. Review.PMID: 17476145 [PubMed - indexed for MEDLINE]Related articles

    26.

    Müllerian inhibiting substance is an accurate marker of ovarian response in women of advanced reproductive age undergoing IVF.

    Nakhuda GS, Sauer MV, Wang JG, Ferin M, Lobo RA.

    Reprod Biomed Online. 2007 Apr;14(4):450-4.PMID: 17425826 [PubMed - indexed for MEDLINE]Related articles

    27.

    Should symptomatic menopausal women be offered hormone therapy?

    Lobo RA, Bélisle S, Creasman WT, Frankel NR, Goodman NF, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S.

    MedGenMed. 2006;8(3):40. Review.PMID: 17410686 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes.

    Carmina E, Lobo RA.

    J Endocrinol Invest. 2007 Feb;30(2):111-6.PMID: 17392600 [PubMed - indexed for MEDLINE]Related articles

    29.

    Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis.

    Vigen C, Hodis HN, Chandler WL, Lobo RA, Mack WJ.

    J Thromb Haemost. 2007 Jun;5(6):1201-8.PMID: 17389005 [PubMed - indexed for MEDLINE]Related articles

    30.

    Formation of ethinyl estradiol in women during treatment with norethindrone acetate.

    Chu MC, Zhang X, Gentzschein E, Stanczyk FZ, Lobo RA.

    J Clin Endocrinol Metab. 2007 Jun;92(6):2205-7. Epub 2007 Mar 6.PMID: 17341557 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.

    Steiner AZ, Xiang M, Mack WJ, Shoupe D, Felix JC, Lobo RA, Hodis HN.

    Obstet Gynecol. 2007 Mar;109(3):581-7.PMID: 17329508 [PubMed - indexed for MEDLINE]Related articles

    32.

    The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study.

    Wang JG, Anderson RA, Graham GM 3rd, Chu MC, Sauer MV, Guarnaccia MM, Lobo RA.

    Fertil Steril. 2007 Jul;88(1):240-3. Epub 2007 Feb 12.PMID: 17296187 [PubMed - indexed for MEDLINE]Related articles

    33.

    Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome.

    Wang JG, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA.

    Am J Obstet Gynecol. 2007 Jan;196(1):77.e1-5.PMID: 17240243 [PubMed - indexed for MEDLINE]Related articles

    34.

    A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.

    Chu MC, Cosper P, Nakhuda GS, Lobo RA.

    Fertil Steril. 2006 Dec;86(6):1669-75. Epub 2006 Oct 30.PMID: 17074346 [PubMed - indexed for MEDLINE]Related articles

    35.

    Should symptomatic menopausal women be offered hormone therapy?

    Lobo RA, Bélisle S, Creasman WT, Frankel NR, Goodman NE, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S.

    MedGenMed. 2006;8(2):1 p preceding 35. Review.PMID: 17048337 [PubMed - indexed for MEDLINE]Related articles

    36.

    Choice of treatment for women with polycystic ovary syndrome.

    Lobo RA.

    Fertil Steril. 2006 Jul;86 Suppl 1:S22-3.PMID: 16798280 [PubMed - indexed for MEDLINE]Related articles

    37.

    What is the effect of estrogen on blood pressure after menopause?

    Lobo RA.

    Menopause. 2006 May-Jun;13(3):331-3. No abstract available. PMID: 16735928 [PubMed - indexed for MEDLINE]Related articles

    38.

    Elevated serum müllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization.

    Nakhuda GS, Chu MC, Wang JG, Sauer MV, Lobo RA.

    Fertil Steril. 2006 May;85(5):1541-3. Epub 2006 Mar 29.PMID: 16566934 [PubMed - indexed for MEDLINE]Related articles

    39.

    Endothelial dysfunction in PCOS: role of obesity and adipose hormones.

    Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB, Lobo RA.

    Am J Med. 2006 Apr;119(4):356.e1-6.PMID: 16564785 [PubMed - indexed for MEDLINE]Related articles

    40.

    Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin.

    Chu MC, Cosper P, Orio F, Carmina E, Lobo RA.

    Am J Obstet Gynecol. 2006 Jan;194(1):100-4.PMID: 16389017 [PubMed - indexed for MEDLINE]Related articles

    41.

    Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.

    Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA.

    Eur J Endocrinol. 2006 Jan;154(1):141-5.PMID: 16382003 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B.

    Chu MC, Carmina E, Wang J, Lobo RA.

    Fertil Steril. 2005 Dec;84(6):1685-8.PMID: 16359965 [PubMed - indexed for MEDLINE]Related articles

    43.

    Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.

    Steiner AZ, Hodis HN, Lobo RA, Shoupe D, Xiang M, Mack WJ.

    Menopause. 2005 Nov-Dec;12(6):728-33. Epub 2005 Nov 8.PMID: 16278616 [PubMed - indexed for MEDLINE]Related articles

    44.

    Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.

    Carmina E, Orio F, Palomba S, Longo RA, Lombardi G, Lobo RA.

    Fertil Steril. 2005 Aug;84(2):413-9.PMID: 16084883 [PubMed - indexed for MEDLINE]Related articles

    45.

    Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT).

    Hwang J, Mack WJ, Xiang M, Sevanian A, Lobo RA, Hodis HN.

    Atherosclerosis. 2005 Aug;181(2):375-80. Epub 2005 Feb 19.PMID: 16039293 [PubMed - indexed for MEDLINE]Related articles

    46.

    Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial.

    Karim R, Mack WJ, Lobo RA, Hwang J, Liu CR, Liu CH, Sevanian A, Hodis HN.

    Menopause. 2005 Jul-Aug;12(4):366-73. Epub 2005 Jul 21.PMID: 16037751 [PubMed - indexed for MEDLINE]Related articles

    47.

    Potential options for preservation of fertility in women.

    Lobo RA.

    N Engl J Med. 2005 Jul 7;353(1):64-73. Review. No abstract available. PMID: 16000356 [PubMed - indexed for MEDLINE]Related articles

    48.

    Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk.

    Lobo RA.

    Maturitas. 2005 May 16;51(1):98-109. Review.PMID: 15883114 [PubMed - indexed for MEDLINE]Related articles

    49.

    Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist.

    Potts RO, Lobo RA.

    Obstet Gynecol. 2005 May;105(5 Pt 1):953-61. Review.PMID: 15863530 [PubMed - indexed for MEDLINE]Related articles

    50.

    Evidence for altered adipocyte function in polycystic ovary syndrome.

    Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM, Lombardi G, Lobo RA.

    Eur J Endocrinol. 2005 Mar;152(3):389-94.PMID: 15757855 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...